⌕
West Pharmaceutical Services · WST · NYSE
Tenet 48 · Mixed
Compare
$416.42+1.24%At closeTenet 48 · Mixed
$416.42+5.12 (+1.24%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD
$417.00+0.58 (+0.14%)
Pre-market: Nov 16, 2026, 8:00 AM ET· last 1-minute bar

West Pharmaceutical Services (WST) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Defense WorldNov 16, 2026 · 03:57 ETEARNINGS EXPECTED BY FEB 16
West Pharmaceutical Services, Inc. $WST Position Increased by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. boosted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 35.8% during a recent quarter, according to its most recent 13F filing with the SEC. The fund owned 20,980 sh…

● Defense WorldNov 9, 2026 · 04:05 ETEARNINGS EXPECTED BY FEB 16
Candriam S.C.A. Purchases 3,140 Shares of West Pharmaceutical Services, Inc. $WST

Candriam S.C.A. boosted its position in West Pharmaceutical Services, Inc. (NYSE: WST) by 3.3% during a recent quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The …

● Zacks Investment ResearchNov 5, 2026 · 13:01 ET
West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?

Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.…

● PRNewsWireNov 4, 2026 · 06:00 ET
West to Participate in Upcoming Investor Conference

EXTON, Pa., Nov. 4, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Jefferies G…

● Defense WorldNov 4, 2026 · 04:01 ETEARNINGS EXPECTED BY FEB 16
West Pharmaceutical Services, Inc. $WST Stock Position Raised by Bank Julius Baer & Co. Ltd Zurich

Bank Julius Baer and Co. Ltd Zurich increased its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 39.8% in a recent quarter, according to the company in its most recent disclosure with the Securities…

● MarketBeatOct 31, 2026 · 02:14 ETEARNINGS EXPECTED BY FEB 16
What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call

West Pharmaceutical Services NYSE: WST reported third-quarter results that exceeded its expectations, driven by continued demand for high-value product components, including those used in GLP-1 therapies and biologics. T…

● Seeking AlphaOct 29, 2026 · 13:39 ETEARNINGS EXPECTED BY FEB 16
West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript

West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript…

● Zacks Investment ResearchOct 29, 2026 · 13:06 ETEARNINGS EXPECTED BY FEB 16
West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook Raised

WST reports strong Q3 earnings and revenue growth, fueled by high-value products and margin expansion, and raises its 2026 sales and earnings outlook.…

● Zacks Investment ResearchOct 29, 2026 · 10:31 ETEARNINGS EXPECTED BY FEB 16
Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estim…

● Zacks Investment ResearchOct 29, 2026 · 08:11 ETEARNINGS EXPECTED BY FEB 16
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $1.96 per share a year ago.…

● PRNewsWireOct 29, 2026 · 06:00 ETEARNINGS EXPECTED BY FEB 16
West Reports Third-Quarter 2026 Results

Raising Full-Year Net Sales and Adjusted-Diluted EPS guidance EXTON, Pa., Oct. 29, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions …

● Zacks Investment ResearchOct 28, 2026 · 10:16 ETEARNINGS EXPECTED BY FEB 16
West Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Get a deeper insight into the potential performance of West Pharmaceutical (WST) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of it…

● Zacks Investment ResearchOct 27, 2026 · 10:41 ETEARNINGS EXPECTED BY FEB 16
WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?

WST's Q3 earnings may benefit from strong HVP demand, biologics and GLP-1 growth, but West Vantage weakness and the SmartDose divestiture could weigh on sales.…

● Zacks Investment ResearchOct 21, 2026 · 10:31 ET
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

West Pharmaceutical???s biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.…

● PRNewsWireOct 19, 2026 · 18:04 ETEARNINGS EXPECTED BY FEB 16
West Declares Quarterly Dividend

EXTON, Pa., Oct. 19, 2026 /PRNewswire/ -- On October 19, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declare…

● Zacks Investment ResearchOct 15, 2026 · 10:25 ETEARNINGS EXPECTED BY FEB 16
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?

West Pharmaceutical Services  WST shares have gained 36.1% year to date, significantly outperforming its industry's advancement of 7.8%. The rally reflects improving demand for high-value pharmaceutical packaging compone…

● Defense WorldOct 15, 2026 · 02:43 ET
West Pharmaceutical Services (NYSE:WST) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

West Pharmaceutical Services, Inc. (NYSE: WST - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $330.99 and t…

● BenzingaOct 14, 2026 · 08:09 ET
Meta, JPMorgan, West Pharmaceutical And More: CNBC's ‘Final Trades'

On CNBC's “Halftime Report Final Trades,” Joseph M. Terranova, senior managing director for Virtus Investment Partners, said he likes West Pharmaceutical Services, Inc. (NYSE:WST).…

● PRNewsWireOct 8, 2026 · 06:00 ETEARNINGS EXPECTED BY FEB 16
West to Host Third-Quarter 2026 Conference Call

EXTON, Pa., Oct. 8, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter fina…

● Seeking AlphaOct 7, 2026 · 07:30 ET
West Pharma: Still A Buy, But Expectations Are Rising

West Pharmaceutical Services remains a buy despite a demanding valuation, driven by new growth catalysts and robust financial performance. Double-digit growth from GLP-1s, HVP upgrades, and the multiyear Annex 1 regulato…

● Zacks Investment ResearchSep 18, 2026 · 10:26 ET
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

West Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.…

● Seeking AlphaSep 14, 2026 · 11:21 ET
West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript…

● Seeking AlphaSep 10, 2026 · 10:57 ET
West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript…

● Defense WorldSep 10, 2026 · 03:45 ETEARNINGS EXPECTED BY FEB 16
West Pharmaceutical Services, Inc. $WST Shares Sold by HB Wealth Management LLC

HB Wealth Management LLC lowered its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 28.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)…

● PRNewsWireAug 26, 2026 · 16:00 ET
West to Participate in Upcoming Investor Conferences

EXTON, Pa., Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following …

No recent releases where the company itself is speaking.

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 16. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA6−3.0%
DPZ3+2.5%
INTC3−5.0%

Article counts from the last market-wide feed page, across every symbol we track and not just WST · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.